- Home
- CME vs BLDEW Comparison
CME vs BLDEW Comparison
Compare CME & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CME
- BLDEW
- Stock Information
- Founded
- CME 1898
- BLDEW N/A
- Country
- CME United States
- BLDEW United States
- Employees
- CME N/A
- BLDEW 281
- Industry
- CME Investment Bankers/Brokers/Service
- BLDEW Transportation Services
- Sector
- CME Finance
- BLDEW Consumer Discretionary
- Exchange
- CME Nasdaq
- BLDEW Nasdaq
- Market Cap
- CME N/A
- BLDEW N/A
- IPO Year
- CME 2002
- BLDEW 2019
- Fundamental
- Price
- CME $238.53
- BLDEW $0.39
- Analyst Decision
- CME Hold
- BLDEW
- Analyst Count
- CME 16
- BLDEW 0
- Target Price
- CME $229.69
- BLDEW N/A
- AVG Volume (30 Days)
- CME 2.7M
- BLDEW N/A
- Earning Date
- CME 02-12-2025
- BLDEW N/A
- Dividend Yield
- CME 4.36%
- BLDEW N/A
- EPS Growth
- CME 13.48
- BLDEW N/A
- EPS
- CME 9.51
- BLDEW N/A
- Revenue
- CME $6,034,400,000.00
- BLDEW N/A
- Revenue This Year
- CME $11.13
- BLDEW N/A
- Revenue Next Year
- CME $2.78
- BLDEW N/A
- P/E Ratio
- CME $25.08
- BLDEW N/A
- Revenue Growth
- CME 13.05
- BLDEW N/A
- 52 Week Low
- CME $190.70
- BLDEW N/A
- 52 Week High
- CME $249.02
- BLDEW N/A
- Technical
- Relative Strength Index (RSI)
- CME 57.47
- BLDEW N/A
- Support Level
- CME $234.06
- BLDEW N/A
- Resistance Level
- CME $238.60
- BLDEW N/A
- Average True Range (ATR)
- CME 4.54
- BLDEW 0.00
- MACD
- CME -0.51
- BLDEW 0.00
- Stochastic Oscillator
- CME 29.88
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.